Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS42001339EBVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS42001337EBVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS42001338EBVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS42001340EBVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS10007097HBVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS10037314HBVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS10039531HBVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS10035112HBVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS10020741HBVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS10048170HBVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TCGA Plot Options
Drug Information
GenePRKCA
DrugBank IDDB00675
Drug NameTamoxifen
Target IDBE0004895
UniProt IDQ05513
Regulation Typeinhibitor
PubMed IDs3157445; 27083550
CitationsO'Brian CA, Liskamp RM, Solomon DH, Weinstein IB: Inhibition of protein kinase C by tamoxifen. Cancer Res. 1985 Jun;45(6):2462-5.@@Radin DP, Patel P: Delineating the molecular mechanisms of tamoxifen's oncolytic actions in estrogen receptor-negative cancers. Eur J Pharmacol. 2016 Jun 15;781:173-80. doi: 10.1016/j.ejphar.2016.04.017. Epub 2016 Apr 12.
GroupsApproved
Direct ClassificationStilbenes
SMILESCCC(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
PathwaysTamoxifen Metabolism Pathway; Tamoxifen Action Pathway
PharmGKBPA451581
ChEMBLCHEMBL83